Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

A success in Toxinology translational research in Brazil: Bridging the gap

Texto completo
Autor(es):
Ferreira, Ana Silvia S. B. S. [1, 2, 3] ; Barraviera, Benedito [1, 3] ; Barraviera, Silvia Regina C. S. [1, 3] ; Abbade, Luciana P. F. [3, 4] ; Caramori, Carlos Antonio [1, 2, 3] ; Ferreira, Jr., Rui Seabra [1, 3]
Número total de Autores: 6
Afiliação do(s) autor(es):
[1] Univ Estadual Paulista UNESP, Sao Paulo State Univ, Botucatu Med Sch, Dept Trop Dis & Image Diag, BR-18610307 Sao Paulo - Brazil
[2] Univ Estadual Paulista UNESP, Botucatu Med Sch, Clin Res Unit UPECLIN, BR-18610307 Sao Paulo - Brazil
[3] Univ Estadual Paulista UNESP, Ctr Study Venoms & Venomous Anim CEVAP, BR-18610307 Sao Paulo - Brazil
[4] Sao Paulo State Univ, Botucatu Med Sch, Dept Dermatol & Radiotherapy, Sao Paulo - Brazil
Número total de Afiliações: 4
Tipo de documento: Artigo Científico
Fonte: Toxicon; v. 69, n. SI, p. 50-54, JUL 2013.
Citações Web of Science: 4
Resumo

Basic research is fundamental for discovering potential diagnostic and therapeutic tools, including drugs, vaccines and new diagnostic techniques. On this basis, diagnosis and treatment methods for many diseases have been developed. Presently, discovering new candidate molecules and testing them in animals are relatively easy tasks that require modest resources and responsibility. However, crossing the animal-to-human barrier is still a great challenge that most researchers tend to avoid. Thus, bridging this current gap between clinical and basic research must be encouraged and elucidated in training programmes for health professionals. This project clearly shows the challenges faced by a group of Brazilian researchers who, after discovering a new fibrin sealant through 20 years of painstaking basic work, insisted on having the product applied clinically. The Brazilian government has recently become aware of this challenge and has accordingly defined the product as strategic to the public health of the country. Thus, in addition to financing research and development laboratories, resources were invested in clinical trials and in the development of a virtual platform termed the Virtual System to Support Clinical Research (SAVPC); this platform imparts speed, reliability and visibility to advances in product development, fostering interactions among sponsors, physicians, students and, ultimately, the research subjects themselves. This pioneering project may become a future model for other public institutions in Brazil, principally in overcoming neglected diseases, which unfortunately continue to afflict this tropical country. (C) 2013 Elsevier Ltd. All rights reserved. (AU)

Processo FAPESP: 09/06280-0 - Variação sexual, ontogenética e ambiental do veneno de Crotalus durissus terrificus e Bothrops Jararaca da região de Botucatu - São Paulo: caracterização enzimática, bioquímica e farmacológica
Beneficiário:Rui Seabra Ferreira Junior
Linha de fomento: Auxílio à Pesquisa - Regular
Processo FAPESP: 09/53846-9 - EMU: aquisição de cromatógrafo líquido de alta eficiência (CLAE) preparativo para purificação e isolamento de serinoproteinases para produção do selante de fibrina
Beneficiário:Benedito Barraviera
Linha de fomento: Auxílio à Pesquisa - Programa Equipamentos Multiusuários